Evidence map›Paper›PMID 40058339›Full record

ReviewRespiration; international review of thoracic diseases2025

Vaccination Strategies in Respiratory Diseases: Recommendation from AIPO-ITS/ETS, SIMIT, SIP/IRS, and SItI.

Claudio Micheletto, Stefano Aliberti, Massimo Andreoni, Francesco Blasi, Fabiano Di Marco, Rosa Di Matteo, Giovanni Gabutti, Sergio Harari, Ivan Gentile, Roberto Parrella and 7 more

Abstract readReview
In one paragraph

Review in Respiration; international review of thoracic diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Observational
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Claudio MichelettoRespiratory Unit, Integrated University Hospital of Verona, Verona, Italy.
Stefano AlibertiDepartment of Biomedical Sciences, Humanitas University, Milan, Italy.
Massimo AndreoniDepartment of System Medicine, Infectious Disease Clinic, University of Tor Vergata, Rome, Italy.
Francesco BlasiDepartment of Pathophysiology and Transplantation, University of Milan, Milan, Italy.
Fabiano Di MarcoDepartment of Health Science, University of Milan, ASST Papa Giovanni XXIII, Bergamo, Italy.
Rosa Di MatteoRespiratory Unit, Hospital Antonio Cardarelli, Naples, Italy.
Giovanni GabuttiNational Coordinator Working Group Vaccines and Immunization Policies, Italian Scientific Society of Hygiene, Preventive Medicine and Public Health (SItI), Cogorno, Italy.
Sergio HarariDivision of Pulmonary and Respiratory Intermediate Care Unit, MultiMedica IRCCS, Milan, Italy.
Ivan GentileDepartment of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
Roberto ParrellaRespiratory Infection Diseases Unit, Cotugno Hospital, AORN Ospedali dei Colli, Naples, Italy.
Roberta SiliquiniUniversity of Torino, AOU Città della Salute e della Scienza, Torino, Italy.
Laura SticchiUniversity of Genoa, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Associazione Italiana Pneumologi Ospedalieri - Italian Thoracic Society (AIPO-ITS/ETS)
Società Italiana di Malattie Infettive e Tropicali (SIMIT)
Società Italiana di Pneumologia/Italian Respiratory Society (SIP/IRS)
Società Italiana di Igiene
Medicina Preventiva e Sanità Pubblica (SItI)

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundChronic respiratory diseases, including asthma, chronic obstructive pulmonary disease, and bronchiectasis, are significant global health concerns associated with recurrent exacerbations, hospitalization, and increased mortality. Preventive strategies, particularly vaccination, play a crucial role in managing these diseases by reducing infection-related exacerbations and stabilizing lung function. SUMMARY: This review summarizes the recommendations provided by four major Italian scientific societies on vaccination against key respiratory pathogens, including respiratory syncytial virus, influenza, SARS-CoV-2, Streptococcus pneumoniae, and varicella zoster virus, which pose serious risks to individuals with chronic respiratory conditions. Evidence supporting the role of vaccines in minimizing exacerbations and improving patient outcomes in asthma, chronic obstructive pulmonary disease, and bronchiectasis is highlighted, alongside recent advancements in vaccine technology and recommendations for high-risk populations. This expert-led, multidisciplinary approach underlines the necessity of targeted immunization strategies to mitigate complications, lower healthcare costs, and enhance the quality of life for patients with respiratory diseases. KEY MESSAGES: By collecting the latest evidence-based recommendations, this article aims to guide healthcare providers in adopting optimal vaccination strategies for respiratory disease management and contribute to the broader public health effort to reduce the burden of respiratory infections.

Indexed as

Respiratory Tract InfectionsVaccinationAsthmaCOVID-19COVID-19 VaccinesHumansInfluenza, HumanInfluenza VaccinesItalyPneumococcal VaccinesPulmonary Disease, Chronic ObstructiveSARS-CoV-2COVID-19 VaccinesInfluenza VaccinesPneumococcal VaccinesChronic respiratory infectionsImmunization recommendationsPreventive healthcareRespiratory diseasesVaccination strategies

Identifiers

PMID40058339
PMCPMC12324705

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.